An Unicenter, Prospective, Randomized, Pilot Study Comparing the Effect of Everolimus-containing Versus mTOR Inhibitor Free Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.
- 04 Jan 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.